| Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial 1994 · slow-release sodium fluoride group · Women with postmenopausal osteoporosis | 50 mg | 913 days | 54 |
| Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy 1998 · Sodium fluoride · Postmenopausal women with osteoporosis and vertebral fractures | 50 mg | 2 years | — |
| Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy 1998 · Monofluorophosphate, 200 mg/day · Postmenopausal women with osteoporosis and vertebral fractures | 200 mg | 2 years | — |
| Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy 1998 · Monofluorophosphate, 150 mg/day · Postmenopausal women with osteoporosis and vertebral fractures | 150 mg | 2 years | — |
| A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy 2025 · Group B (PEG) · Men and women aged 18–70 years undergoing screening, surveillance, or diagnostic colonoscopy | 46.6 mg | 1 day | 355 |
| Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial 2017 · sodium phosphate group · Outpatients at a VA hospital undergoing screening colonoscopy; mean age 62 years, 75% men | 180 mL | 1 day | 127 |
| Phase III Randomized Non-Inferiority Study of OSS Versus PEG + Electrolyte Colonoscopy Preparation in Adolescents 2023 · OSS · Adolescents aged 12–17 years, weighing >40 kg, scheduled for diagnostic colonoscopy | 750 mL | 1 day | 125 |
| Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial 2023 · OSS group · Adults older than 19 years with clinically inactive ulcerative colitis | 354 mL | 1 day | 99 |
| Does prucalopride reduce the dose of sodium phosphate in bowel preparation? A single-blind, randomized, and prospective study 2019 · P-NaP · Adults undergoing a screening colonoscopy | 45 mL | 1 day | 97 |
| Comparison of standard polyethylene glycol and two doses of oral sodium phosphate solution in precolonoscopy bowel preparation: a randomized controlled trial 2008 · NaP group · Patients undergoing precolonoscopy bowel preparation; age and sex not reported | 40 mL | 1 day | 94 |
| Magnesium citrate with a single dose of sodium phosphate for colonoscopy bowel preparation 2011 · Group I · Patients undergoing colonoscopy; age and sex not specified | 180 mg | 1 day | 79 |
| A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial 2012 · NaP group · Lynch syndrome gene carriers scheduled for surveillance colonoscopy, adults; age range not specified | 90 mL | 2 days | 63 |
| Efficacy and safety of oral sodium phosphate versus polyethylene glycol solution for bowel preparation for colonoscopy 2002 · oral sodium phosphate group · People undergoing colonoscopy for various indications | 90 mL | 1 day | 50 |
| Low volume bowel preparation for colonoscopy: randomized, endoscopist-blinded trial of liquid sodium phosphate versus tablet sodium phosphate 2003 · liquid preparation · Outpatients undergoing elective colonoscopy; adults, age range not reported | 90 mL | 1 day | 50 |
| Short report: prospective, randomized trial comparing a single dose sodium phosphate regimen with PEG-electrolyte lavage for colonoscopy preparation 1993 · single-dose sodium phosphate regimen · Patients undergoing colonoscopy | 89 mL | 1 day | 26 |
| Effects of Short-Term Phosphate Loading on Aerobic Capacity under Acute Hypoxia in Cyclists: A Randomized, Placebo-Controlled, Crossover Study 2022 · Sodium phosphate (SP) phase · Trained male cyclists, mean age 34.8 ± 4.7 years | 50 mg/kg | 6 days | 22 |
| The Effects of Sodium Phosphate Supplementation on the Cardiorespiratory System and Gross Efficiency during Exercise under Hypoxia in Male Cyclists: A Randomized, Placebo-Controlled, Cross-Over Study 2021 · sodium phosphate supplementation phase · trained male cyclists aged 34.6 ± 4.3 years, with normal blood ion levels | 50 mg/kg | 6 days | 20 |
| Effect of Pre-exercise Sodium Citrate Ingestion on Repeated Sprint Performance in Soccer Players 2024 · Sodium citrate (CIT) · Male soccer players; mean age 20.9 ± 2.3 years | 500 mg/kg | 1 day | 20 |
| Adverse cardiovascular effects of acute salt loading in young normotensive individuals 2008 · salt tablets · young healthy normotensive male volunteers | 200 mmol | 5 days | 16 |
| Effects of sodium phosphate and caffeine ingestion on repeated-sprint ability in male athletes 2016 · SP · Male team-sport athletes | 50 mg/kg | 6 days | 11 |
| Coconut Water Does Not Improve Markers of Hydration During Sub-maximal Exercise and Performance in a Subsequent Time Trial Compared with Water Alone 2017 · coconut water (CW) · 10 males, mean age 27.9 years, completing submaximal cycling and a subsequent time trial | 750 mL | 1 day | 10 |
| Sodium citrate supplementation enhances tennis skill performance: a crossover, placebo-controlled, double blind study 2019 · sodium citrate (SC) condition · Nationally ranked male tennis players, age 17 ± 1 years | 500 mg/kg | 1 day | 10 |
| Bicarbonate Unlocks the Ergogenic Action of Ketone Monoester Intake in Endurance Exercise 2021 · BIC · Well-trained male cyclists, mean age 29 years; no stated diagnosed condition | 300 mg/kg | 1 day | 9 |
| An iso-osmolar oral supplement increases natriuresis and does not increase stomal output in patients with an ileostomy: A randomised, double-blinded, active comparator, crossover intervention study 2019 · iso-osmolar oral supplement · Adults with an ileostomy who were independent of parenteral support | 800 mL | 2 days | 8 |
| An iso-osmolar oral supplement increases natriuresis and does not increase stomal output in patients with an ileostomy: A randomised, double-blinded, active comparator, crossover intervention study 2019 · hyperosmolar oral supplement · Adults with an ileostomy who were independent of parenteral support | 800 mL | 2 days | 8 |
| Effect of sodium phosphate supplementation on repeated high-intensity cycling efforts 2015 · sodium phosphate group · trained male cyclists | 50 mg/kg | 6 days | 7 |
| Sodium phosphate loading improves laboratory cycling time-trial performance in trained cyclists 2008 · sodium phosphate (SP) · Six trained male cyclists; age not reported | 4 g | 6 days | 6 |
| Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation 2003 · Transipeg 5.9 g · Ambulatory patients with idiopathic chronic constipation | 5.9 g | 30 days | — |
| Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation 2003 · Transipeg 11.8 g · Ambulatory patients with idiopathic chronic constipation | 11.8 g | 30 days | — |
| A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing 2004 · Fleet Prep Kit 3 (FPK #3) · Patients undergoing colonoscopy; age and sex not reported | 45 mL | 1 day | — |
| Prospective randomized comparison of oral sodium phosphate and polyethylene glycol lavage for colonoscopy preparation 2005 · sodium phosphate (NaP) group · Taiwanese patients undergoing colonoscopy; age and sex not reported | 90 mL | 1 day | — |
| Prospective blinded trial comparing 45-mL and 90-mL doses of oral sodium phosphate for bowel preparation before computed tomographic colonography 2007 · single-dose group · Adults undergoing screening computed tomographic colonography; sex and age not stated | 45 mL | 1 day | — |
| Prospective blinded trial comparing 45-mL and 90-mL doses of oral sodium phosphate for bowel preparation before computed tomographic colonography 2007 · double-dose group · Adults undergoing screening computed tomographic colonography; sex and age not stated | 90 mL | 1 day | — |
| High-dose bisacodyl plus water lavage compared with oral sodium phosphate as bowel preparation for outpatient colonoscopy 2009 · oral sodium phosphate (NaP) preparation · Adults undergoing elective colonoscopy | 90 mL | — | — |
| [Bronchial asthma and kitchen salt] 1991 · salt loading · 14 people with asthma; age and sex not reported | 6.1 g | — | — |
| A randomized controlled trial of four precolonoscopy bowel cleansing regimens 2011 · 90 mL sodium phosphate (NaP) · Patients undergoing outpatient colonoscopy; age and sex not reported | 90 mL | 1 day | — |
| The Effect of Hypo-Hydration on Mood and Cognition Is Influenced by Electrolyte in a Drink and Its Colour: A Randomised Trial 2019 · Electrolyte capsule plus no water · Healthy adults aged 18–30 years | 600 mg | 1 day | — |
| The Effect of Hypo-Hydration on Mood and Cognition Is Influenced by Electrolyte in a Drink and Its Colour: A Randomised Trial 2019 · Electrolyte capsule plus 300 mL plain water · Healthy adults aged 18–30 years | 600 mg | 1 day | — |
| The Effect of Hypo-Hydration on Mood and Cognition Is Influenced by Electrolyte in a Drink and Its Colour: A Randomised Trial 2019 · Electrolyte capsule plus 300 mL coloured water · Healthy adults aged 18–30 years | 600 mg | 1 day | — |
| Efficacy of standard glucose-based and reduced-osmolarity maltodextrin-based oral rehydration solutions: effect of sugar malabsorption 1996 · standard ORS · Boys aged 3–24 months with acute noncholera diarrhoea and moderate dehydration | 20 g | — | — |
| Efficacy of standard glucose-based and reduced-osmolarity maltodextrin-based oral rehydration solutions: effect of sugar malabsorption 1996 · MD-ORS · Boys aged 3–24 months with acute noncholera diarrhoea and moderate dehydration | 50 g | — | — |
| Cleansing ability and tolerance of three bowel preparations for colonoscopy 1997 · Group B · Patients requiring colonoscopy | 90 mL | — | — |
| Cleansing ability and tolerance of three bowel preparations for colonoscopy 1997 · Group C · Patients requiring colonoscopy | 90 mL | — | — |
| A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy 2025 · Group A (OSS) · Men and women aged 18–70 years undergoing screening, surveillance, or diagnostic colonoscopy | 17.5 g | 1 day | 324 |
| Efficacy and tolerability of split-dose PEG compared with split-dose aqueous sodium phosphate for outpatient colonoscopy: a randomized, controlled trial 2011 · NaP group · Healthy outpatients aged 18–65 years with recently documented normal renal function scheduled for colonoscopy | 66 g | 1 day | 104 |
| Evaluation of the efficacy of 1 L polyethylene glycol plus ascorbic acid and an oral sodium sulfate solution: A multi-center, prospective randomized controlled trial 2022 · OSS (SUPREP) · Outpatients aged 20–65 undergoing colonoscopy for diagnosis, screening, surveillance, or treatment | 44.5 g | 1 day | 87 |
| A prospective randomized clinical study evaluating the efficacy and compliance of oral sulfate solution and 2-L ascorbic acid plus polyethylene glycol 2020 · OSS · Adults aged 20–70 undergoing screening colonoscopy | 44.5 g | 1 day | 86 |
| Magnesium citrate with a single dose of sodium phosphate for colonoscopy bowel preparation 2011 · Group II · Patients undergoing colonoscopy; age and sex not specified | 45 mL | 2 days | 80 |
| Colonoscopy preparation: polyethylene glycol with Gatorade is as safe and efficacious as four liters of polyethylene glycol with balanced electrolytes 2012 · PEG + Gatorade arm · Adults referred for outpatient colonoscopy, without the specified exclusion conditions | 1.12 g | 1 day | 66 |
| A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial 2012 · PEG group · Lynch syndrome gene carriers scheduled for surveillance colonoscopy, adults; age range not specified | 15 g | 2 days | 53 |
| Efficacy and safety of 1 L polyethylene glycol plus ascorbic acid for bowel preparation in elderly: comparison with oral sulfate solution 2023 · OSS · Adults aged 65–84 undergoing screening or surveillance colonoscopy; older adults, with or without comorbidities | 88.9 g | 1 day | 52 |
| The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study 2022 · High-dose group · Children aged 1–12 years, both sexes, with X-linked hypophosphatemia | 30 mg/kg | 2 years | 36 |
| The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study 2022 · Low-dose group · Children aged 1–12 years, both sexes, with X-linked hypophosphatemia | 30 mg/kg | 2 years | 32 |
| Effects of sodium phosphate and caffeine ingestion on repeated-sprint ability in male athletes 2016 · SP+C · Male team-sport athletes | 50 mg/kg | 6 days | 11 |
| Bicarbonate Unlocks the Ergogenic Action of Ketone Monoester Intake in Endurance Exercise 2021 · KE + BIC · Well-trained male cyclists, mean age 29 years; no stated diagnosed condition | 300 mg/kg | 1 day | 9 |
| Physiological and performance effects of carbohydrate gels consumed prior to the extra-time period of prolonged simulated soccer match-play 2016 · Carbohydrate-electrolyte gel · English Premier League academy soccer players; age and sex not stated | 700 mg/kg | 1 day | 8 |
| Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man 1990 · Control solution containing equimolar amounts of cations as the chloride salt · 10 mildly hypertensive and 10 normal subjects | 138 mmol | 7 days | 20 |
| Effects of sodium salts on plasma renin activity and norepinephrine response to orthostasis in salt-sensitive normotensive subjects 1993 · sodium chloride · Normotensive salt-sensitive and salt-resistant subjects; ages and sex not reported | 200 mmol | 7 days | 15 |
| Effects of sodium salts on plasma renin activity and norepinephrine response to orthostasis in salt-sensitive normotensive subjects 1993 · sodium citrate · Normotensive salt-sensitive and salt-resistant subjects; ages and sex not reported | 200 mmol | 7 days | 15 |
| High dietary salt intake increases carotid blood pressure and wave reflection in normotensive healthy young men 2011 · high-salt intake · Healthy normotensive men aged 22–40 years | 128 mmol | 6 weeks | 10 |
| Bone mineralization and plasma concentrations of electrolytes in healthy subjects after exposure to hypokinesia and hyperhydration 1993 · 1st group (hypokinesia with daily fluid and salt supplements) · Physically conditioned long-distance runners aged 19–24 years exposed to hypokinesia | 160 mg/kg | 52 weeks | 10 |
| Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects 1993 · 80 mmol/24 h sodium supplement phase · Untreated adults aged 66–79 with essential hypertension | 80 mmol | 10 weeks | — |
| Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients 1997 · sodium chloride · Adults with uncomplicated hypertension controlled by isradipine and urinary sodium levels below 120 mmol/24 h | 100 mmol | 4 weeks | — |
| Efficacy and tolerability of split-dose PEG compared with split-dose aqueous sodium phosphate for outpatient colonoscopy: a randomized, controlled trial 2011 · Split-dose PEG group · Healthy outpatients aged 18–65 years with recently documented normal renal function scheduled for colonoscopy | 38.3 g | 1 day | 103 |
| Evaluation of the efficacy of 1 L polyethylene glycol plus ascorbic acid and an oral sodium sulfate solution: A multi-center, prospective randomized controlled trial 2022 · 1 L PEG/Asc (CleanViewAL) · Outpatients aged 20–65 undergoing colonoscopy for diagnosis, screening, surveillance, or treatment | 21.7 g | 1 day | 85 |
| Colonoscopy preparation: polyethylene glycol with Gatorade is as safe and efficacious as four liters of polyethylene glycol with balanced electrolytes 2012 · 4L PEG-ELS arm · Adults referred for outpatient colonoscopy, without the specified exclusion conditions | 38.3 g | 1 day | 70 |
| Efficacy and safety of 1 L polyethylene glycol plus ascorbic acid for bowel preparation in elderly: comparison with oral sulfate solution 2023 · 1 L PEG/Asc · Adults aged 65–84 undergoing screening or surveillance colonoscopy; older adults, with or without comorbidities | 43.4 g | 1 day | 52 |
| Creatine-electrolyte supplementation improves repeated sprint cycling performance: A double blind randomized control study 2018 · creatine-electrolyte (CE) group · Male recreational cyclists aged 19–33 years | 742 mg | 6 weeks | 12 |
| Creatine electrolyte supplement improves anaerobic power and strength: a randomized double-blind control study 2019 · experimental MIPS group · Recreationally strength-trained healthy college-aged adults aged 19–24 years, male and female | 1.6 g | 6 weeks | 12 |
| Impact of supplementation with bicarbonate on lower-extremity muscle performance in older men and women 2010 · potassium bicarbonate group · Healthy ambulatory men and postmenopausal women aged 50 years and older | 67.5 mmol | 90 days | — |
| Impact of supplementation with bicarbonate on lower-extremity muscle performance in older men and women 2010 · sodium bicarbonate group · Healthy ambulatory men and postmenopausal women aged 50 years and older | 67.5 mmol | 90 days | — |
| Impact of supplementation with bicarbonate on lower-extremity muscle performance in older men and women 2010 · potassium chloride group · Healthy ambulatory men and postmenopausal women aged 50 years and older | 67.5 mmol | 90 days | — |
| Effects of creatine supplementation on body composition, strength, and sprint performance 1998 · Phosphagen HP (HP) · NCAA Division IA football players undergoing resistance/agility training; age and sex not stated | 1.1 g | 4 weeks | — |
| Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide 2016 · TPTD group · Postmenopausal women and men with osteoporosis; age range not stated | 30 mg | 72 weeks | 153 |
| Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide 2016 · Placebo group · Postmenopausal women and men with osteoporosis; age range not stated | 30 mg | 72 weeks | 137 |
| The effect of low-dose cyclical etidronate and calcium on bone mass in early postmenopausal women 1993 · group 3 · Healthy early postmenopausal women; mean age 53.9 years | 2 g | 2 years | 10 |
| Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study 1999 · MFP · Postmenopausal women aged 60–70 years | 20 mg | 96 weeks | — |
| Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study 1999 · HRT+MFP · Postmenopausal women aged 60–70 years | 20 mg | 96 weeks | — |
| Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study 1995 · FC (sodium monofluorophosphate and calcium) · Patients aged 50–70 years with severe osteopenia and no previous vertebral fracture | 200 mg | 2 years | — |
| In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study 1996 · MFP-Ca group · Adults aged 21–65 with asthma or other respiratory diseases who had received long-term corticosteroid treatment | 200 mg | 2 years | — |
| Efficacy of Furosemide, Oral Sodium Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label Randomized Controlled Study (The EFFUSE-FLUID Trial) 2020 · fluid restriction, furosemide, and NaCl (FR+FM+NaCl) · Patients with SIAD and serum sodium concentrations ≤130 mmol/L | 3 g | 4 weeks | 31 |
| Acute Effects of an Inorganic Phosphorus Additive on Mineral Metabolism and Cardiometabolic Risk Factors in Healthy Subjects 2022 · oral phosphorus · Healthy male and female adults from the general community | 700 mg | 1 day | 29 |
| Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate 1992 · sodium fluoride (NaF) · Postmenopausal women aged 48–77 years without bone disease | 25 mg | 1 day | 10 |
| Effects of phosphate loading on oxygen uptake, ventilatory anaerobic threshold, and run performance 1990 · tribasic sodium phosphate · Male competitive runners; mean VO2max 73.9 ± 6.3 ml·kg−1·min−1 | 4 g | 6 days | 7 |
| Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function 2014 · high sodium soup · 16 healthy normotensive adults | 65 mmol | 1 day | — |
| Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function 2014 · low sodium soup · 16 healthy normotensive adults | 5 mmol | 1 day | — |
| Safety and efficacy of oral rehydration therapy until 2 h before surgery: a multicenter randomized controlled trial 2012 · ORS group · Adults aged 20–80 years, ASA physical status I or II, scheduled for elective morning surgery under general anesthesia | 1,000 mL | 1 day | 150 |
| Effect of oral hypotonic water and isotonic saline on physiological intestinal (18)F-FDG uptake in PET/CT imaging 2026 · isotonic group · Adults with various clinical conditions, including cancers and other diseases; age and sex varied | 500 mL | 1 day | 82 |
| Novel Mechanism for Buffering Dietary Salt in Humans: Effects of Salt Loading on Skin Sodium, Vascular Endothelial Growth Factor C, and Blood Pressure 2017 · slow sodium · Healthy adults aged 18–50 years | 200 mmol | 7 days | 48 |
| Beneficial Effects of Long-Lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 2025 · Group A · Adults aged 18 years or older with MASLD, without advanced fibrosis | 400 mL | 1 year | 44 |
| Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study 2020 · sodium supplementation · Adults aged 40–80 with untreated prehypertension (fasting office systolic blood pressure 130–159 mm Hg); predominantly male | 3 g | 4 weeks | 36 |
| Parental history of hypertension, sodium loading, and cardiovascular response to stress 1995 · sodium loading · Normotensive offspring of hypertensive and normotensive parents | 10 g | 2 weeks | 36 |
| Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial 2023 · test group · Patients with type I bipolar disorder receiving maintenance lithium therapy | 1 g | 12 weeks | 30 |
| Effects of sodium sulfate on fecal pH and proliferation of colonic mucosa in patients at high risk for colon cancer 1990 · sodium sulfate · Patients with previously removed colonic polyps, at high risk for colon cancer; age and sex range not reported | 4 g | 2 weeks | 27 |
| Effect of sodium balance on levels of nitrates in healthy subjects: Posthoc analysis of a randomized, double-blinded, placebo-controlled, crossover study 2025 · High sodium period (sodium chloride tablets) · Healthy adults aged 18–50 years, men and women | 750 mg | 4 days | 27 |
| Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses 2003 · High-salt diet · Normotensive subjects; age and sex not reported | 400 mmol | 6 days | 25 |
| Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses 2003 · Low-salt diet · Normotensive subjects; age and sex not reported | 10 mmol | 6 days | 25 |
| The effect of acute fluid consumption on measures of impedance and percent body fat using leg-to-leg bioelectrical impedance analysis 2006 · CHOE trial · Recreationally active men, mean age 19.7 years; no condition reported | 591 mL | 1 day | 21 |
| Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach 2007 · phosphate supplement session · Healthy women aged 20–30 years | 1 g | 1 day | 16 |
| Water drinking induces thermogenesis through osmosensitive mechanisms 2007 · 500 ml isoosmotic saline · Overweight or obese, otherwise healthy men and women; ages not reported | 500 mL | 1 day | 16 |
| Impact of 3-day high and low dietary sodium intake on sodium status in response to exertional-heat stress: a double-blind randomized control trial 2019 · Low-sodium diet (LNa) · Male endurance athletes: runners and cyclists; age and health condition not stated | 15 mg/kg | 3 days | 15 |
| Impact of 3-day high and low dietary sodium intake on sodium status in response to exertional-heat stress: a double-blind randomized control trial 2019 · High-sodium diet (HNa) · Male endurance athletes: runners and cyclists; age and health condition not stated | 100 mg/kg | 3 days | 15 |
| Impact of 3-day high and low dietary sodium intake on sodium status in response to exertional-heat stress: a double-blind randomized control trial 2019 · Usual free-living diet (UDiet) · Male endurance athletes: runners and cyclists; age and health condition not stated | 46 mg/kg | 3 days | 15 |
| The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension 1994 · High salt intake · 15 patients with mild essential hypertension | 200 mmol | 7 days | 15 |
| The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension 1994 · Low salt intake · 15 patients with mild essential hypertension | 50 mmol | 7 days | 15 |
| Mono- and polyphosphates have similar effects on calcium and phosphorus metabolism in healthy young women 2013 · MP session · Healthy women aged 19–31 years | 1.5 g | 1 day | 14 |
| Mono- and polyphosphates have similar effects on calcium and phosphorus metabolism in healthy young women 2013 · PP session · Healthy women aged 19–31 years | 1.5 g | 1 day | 14 |
| Ingestion of sodium citrate suppresses aldosterone level in blood at rest and during exercise 2010 · CIT trial · Young male well-trained runners | 500 mg/kg | 1 day | 13 |
| Extracellular buffer choice influences acid-base responses and gastrointestinal symptoms 2021 · sodium citrate condition · Active males, mean age 20.5 ± 2.1 years | 300 mg/kg | 1 day | 13 |
| The natriuretic effect of lithium in man: is the proximal tubule involved? 1995 · 100 mg lithium carbonate · 12 healthy adult males on a fixed sodium intake | 100 mg | 1 day | 12 |
| The natriuretic effect of lithium in man: is the proximal tubule involved? 1995 · 600 mg lithium carbonate · 12 healthy adult males on a fixed sodium intake | 600 mg | 1 day | 12 |
| Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD 2013 · ad libitum diet plus LC · Patients with CKD stages 3 or 4 and normal serum phosphate levels | 3 g | 90 days | 11 |
| Effect of acid-base balance on the growth hormone response to acute high-intensity cycle exercise 1994 · alkalosis (ALK) · Normally active, untrained men aged 24.6 ± 1.5 years | 300 mg/kg | 1 day | 10 |
| Effect of acid-base balance on the growth hormone response to acute high-intensity cycle exercise 1994 · control (CTRL) · Normally active, untrained men aged 24.6 ± 1.5 years | 40 mg/kg | 1 day | 10 |
| An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women 1996 · P1 phosphate dose · Female volunteers; age and health status not specified | 1.5 g | 1 day | 10 |
| Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD 2013 · 900-mg phosphate diet plus LC · Patients with CKD stages 3 or 4 and normal serum phosphate levels | 3 g | 90 days | 8 |
| Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution 1992 · Sodium chloride in gelatine capsules · Six patients with jejunostomies and residual jejunal lengths of 105 to 250 cm | 120 mmol | 2 days | 6 |
| Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution 1992 · Isotonic glucose electrolyte solution · Six patients with jejunostomies and residual jejunal lengths of 105 to 250 cm | 120 mmol | 2 days | 6 |
| Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution 1992 · Glucose polymer electrolyte solution · Six patients with jejunostomies and residual jejunal lengths of 105 to 250 cm | 120 mmol | 2 days | 6 |
| Serum electrolyte, serum protein, serum fat and renal responses to a dietary sodium challenge: allostasis and allostatic load 2004 · low-sodium diet · Middle-aged adults with mild, uncomplicated borderline hypertension; 38 men and 10 women across the study | 24 mmol | 30 days | — |
| Serum electrolyte, serum protein, serum fat and renal responses to a dietary sodium challenge: allostasis and allostatic load 2004 · high-sodium diet · Middle-aged adults with mild, uncomplicated borderline hypertension; 38 men and 10 women across the study | 309 mmol | 30 days | — |
| Efficacy and tolerance of sodium phosphates oral solution after diet liberalization 2005 · Standard light breakfast followed by clear liquids · People undergoing colonoscopy; age and sex not reported | 90 mL | 1 day | — |
| Efficacy and tolerance of sodium phosphates oral solution after diet liberalization 2005 · Normal breakfast followed by a low-residue lunch · People undergoing colonoscopy; age and sex not reported | 90 mL | 1 day | — |
| Induced Alkalosis and Gastrointestinal Symptoms After Sodium Citrate Ingestion: a Dose-Response Investigation 2016 · 500 mg⋅kg−1 sodium citrate · 13 participants; age and sex not reported; exercise context, with no condition specified | 500 mg/kg | 1 day | — |
| Induced Alkalosis and Gastrointestinal Symptoms After Sodium Citrate Ingestion: a Dose-Response Investigation 2016 · 700 mg⋅kg−1 sodium citrate · 13 participants; age and sex not reported; exercise context, with no condition specified | 700 mg/kg | 1 day | — |
| Induced Alkalosis and Gastrointestinal Symptoms After Sodium Citrate Ingestion: a Dose-Response Investigation 2016 · 900 mg⋅kg−1 sodium citrate · 13 participants; age and sex not reported; exercise context, with no condition specified | 900 mg/kg | 1 day | — |
| High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults 2022 · salt · healthy young adults; age range and sex not specified | 3.9 g | 10 days | — |
| Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery - The DeFICIT trial 2025 · phosphate group · Adults with isolated iron deficiency or iron deficiency anemia scheduled for elective major abdominal or thoracic surgery | 18 mmol | 30 days | 46 |
| High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women 2019 · 3:1 NaPP:57Fe ratio · Women aged 18–35 with low iron status, recruited in Nigeria | 72 mg | 5 days | 23 |
| High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women 2019 · 6:1 NaPP:57Fe ratio · Women aged 18–35 with low iron status, recruited in Nigeria | 144 mg | 5 days | 23 |
| Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate 1992 · disodium monofluorophosphate-calcium carbonate (MFP-Ca) · Postmenopausal women aged 48–77 years without bone disease | 100 mg | 1 day | 10 |
| Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels 2025 · Low Pi diet · Healthy men aged 20–40 years with normal kidney function and mineral metabolism | 3 g | 5 days | 10 |
| Small bowel absorption of magnesium and calcium sulphate from a natural mineral water in subjects with ileostomy 2006 · High-mineral-content natural mineral water · Six subjects with ileostomy | 7.7 mmol | 2 days | 6 |
| Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis 1996 · Low-calcium mineral water · 21 patients with idiopathic calcium nephrolithiasis; age and sex not reported | 0.5 mmol | 30 days | 21 |
| Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis 1996 · Intermediate-calcium mineral water · 21 patients with idiopathic calcium nephrolithiasis; age and sex not reported | 10 mmol | 30 days | 21 |
| Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis 1996 · High-calcium, alkaline mineral water · 21 patients with idiopathic calcium nephrolithiasis; age and sex not reported | 50 mmol | 30 days | 21 |
| Oxygen delivery and cardiac output during exercise following oral phosphate-glucose 1990 · PHOS · 10 normal fasting adult males | 129 mmol | 1 day | 10 |
| Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine 1992 · Group II · Postmenopausal women with osteoporosis and at least one vertebral crush fracture | 750 mg | 2 years | — |
| Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis 1994 · phosphate/placebo · Postmenopausal women with vertebral compression fractures | 2 g | 104 weeks | — |
| Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis 1994 · phosphate/etidronate · Postmenopausal women with vertebral compression fractures | 2 g | 104 weeks | — |
| Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women 2024 · Group 1 (one stick of product) · Healthy men and women aged 18–50 years with BMI 20–29.9 kg/m² | 510 mg | 4 weeks | 10 |
| Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers 1995 · Salt repletion with active salt replacement · Eight healthy adult volunteers; age and sex not reported | 100 mmol | 4 days | 8 |
| [Bronchial asthma and kitchen salt] 1991 · sodium citrate loading · 14 people with asthma; age and sex not reported | 140 mL | — | — |
| Effects of potassium supplementation on markers of osmoregulation and volume regulation: results of a fully controlled dietary intervention study 2016 · sodium · (Pre)hypertensive individuals; ages and sex not reported | 3 g | 4 weeks | — |